Avenue Therapeutics, Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATXI Avenue Therapeutics, Inc.

Trading 10-26 10:49:36 EDT Delay

{"stockData":{"symbol":"ATXI","market":"US","secType":"STK","nameCN":"Avenue Therapeutics, Inc.","latestPrice":0.4018,"timestamp":1793026176605,"preClose":0.385,"halted":0,"volume":3000,"delay":15,"changeRate":0.043636363636363584,"floatShares":1496100,"shares":2053899,"eps":-0.547589,"marketStatus":"Trading","change":0.0168,"latestTime":"10-26 10:49:36 EDT Delay","open":0.4018,"high":0.4018,"low":0.4018,"amount":1205.3999999999999,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.547589,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793044800000},"marketStatusCode":2,"adr":0,"listingDate":1497585600000,"exchange":"PINK LIMITED","adjPreClose":0.385,"volumeRatio":186.781998},"requestUrl":"/m/hq/s/ATXI/","defaultTab":"news","newsList":[{"id":"2657211614","title":"Avenue Therapeutics Q2 Net Loss Narrows to $690,000; Revenue Drops to no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2657211614","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657211614?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:03","pubTimestamp":1786097030,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics Q2 net loss narrows to $690,000; revenue drops to no revenueAvenue Therapeutics posted a net loss of USD 690,000 for the quarter ended June 30, 2026, swinging from net income of US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL2Trq3N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXI","FBIO","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633567774","title":"Avenue Therapeutics Q1 net loss narrows to $695,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2633567774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633567774?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:34","pubTimestamp":1778243645,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics posted a net loss of $695,000, or $0.21 per share, for the quarter ended March 31, 2026.Operating loss narrowed to $714,000 as operating expenses fell to $714,000, reflecting research and development expense of $200,000 and general and administrative expense of $514,000.Cash and cash equivalents declined to $2.42 million, with net cash used in operating activities of $438,000.Company highlighted February 2026 exclusive worldwide license from Duke University for ATX-04  in Pompe disease, with upfront payments totaling about $19,000 and milestone obligations totaling about $15.6 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avenue Therapeutics Inc. published the original content used to generate this news br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDLbP3d4s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FBIO","BK4139","ATXI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avenuetx.com","description":"Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.","exchange":"PINK LIMITED","name":"Avenue Therapeutics, Inc.","nameEN":"Avenue Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avenue Therapeutics, Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avenue Therapeutics, Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avenue Therapeutics, Inc.,ATXI,Avenue Therapeutics, Inc.股票,Avenue Therapeutics, Inc.股票老虎,Avenue Therapeutics, Inc.股票老虎国际,Avenue Therapeutics, Inc.行情,Avenue Therapeutics, Inc.股票行情,Avenue Therapeutics, Inc.股价,Avenue Therapeutics, Inc.股市,Avenue Therapeutics, Inc.股票价格,Avenue Therapeutics, Inc.股票交易,Avenue Therapeutics, Inc.股票购买,Avenue Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avenue Therapeutics, Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avenue Therapeutics, Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction